512
Views
6
CrossRef citations to date
0
Altmetric
Review

Immune checkpoint inhibitor-induced inflammatory arthritis: identification and management

ORCID Icon, ORCID Icon, &
Pages 771-785 | Received 02 Jun 2020, Accepted 29 Jul 2020, Published online: 24 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christopher Aboo, Tue Wenzel Krastrup, Helene Broch Tenstad, Jie Ren, Søren Andreas Just, Morten Ladekarl & Allan Stensballe. (2022) Prediction and early diagnosis of immune-checkpoint inhibitor-induced inflammatory arthritis from molecular biomarkers – Where are we now?. Expert Review of Precision Medicine and Drug Development 7:1, pages 162-168.
Read now

Articles from other publishers (5)

Melissa Defoe & Bonnie L. Bermas. (2023) Rheumatologic immune checkpoint inhibitor-related adverse events. Current Opinion in Rheumatology 35:3, pages 141-148.
Crossref
Nerina Denaro, Ornella Garrone, Annamaria Morelli, Benedetta Pellegrino, Marco Carlo Merlano, Denise Vacca, Josie Pearce, Daniele Farci, Antonino Musolino, Mario Scartozzi, Chiara Tommasi & Cinzia Solinas. (2022) A narrative review of the principal glucocorticoids employed in cancer. Seminars in Oncology 49:6, pages 429-438.
Crossref
Takeshi Azuma, Masato Kano, Shohei Iwata, Sachi Honda, Yuji Miyoshi & Junko Nishiguchi. (2022) Utility of periodic medical questionnaires and examinations for immune-related adverse event screening: A prospective observational study. PLOS ONE 17:9, pages e0274451.
Crossref
Youngmin Cho, Erik W Anderson, Sara J Guevara, Santiago J Miyara, Naomi Maria, Christine N Metz, Stefanos Zafeiropoulos, Dimitrios Giannis, Jifeng Wang, Oluseyi Abidoye, James M Mumford, Judith Aronsohn, Ernesto Molmenti & Huma Sohail. (2021) Diagnostic Dilemma of Paraneoplastic Rheumatic Disorders: Case Series and Narrative Review. Cureus.
Crossref
Kaijian Zhou, Shu Guo, Fei Li, Qiang Sun & Guoxin Liang. (2020) Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies. Frontiers in Cell and Developmental Biology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.